A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors
Clinical trial NCT05387265 · TERMINATED
Trial details
- NCT number
- NCT05387265
- Sponsor
- CytomX Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2025-06-04
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.